Tanvex BioPharma Inc TANVF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- $0.00 / —
- Market Cap
- —
- Volume/Avg
- — / 0
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in the research, development, manufacture, and sale of biosimilar products. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.tanvex.com
Comparables
Valuation
|
Metric
|
TANVF
|
6617
|
09966
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | — | 15.68 | 2.44 |
Price/Sales | — | 1,095.74 | 18.52 |
Price/Cash Flow | — | — | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
TANVF
|
6617
|
09966
|
|---|---|---|---|
Quick Ratio | 1.08 | 9.71 | 6.35 |
Current Ratio | 1.66 | 9.91 | 6.59 |
Interest Coverage | −36.74 | −21.66 | −25.61 |
Quick Ratio
TANVF
6617
09966
Profitability
|
Metric
|
TANVF
|
6617
|
09966
|
|---|---|---|---|
Return on Assets (Normalized) | −55.13% | −6.36% | −11.93% |
Return on Equity (Normalized) | −141.14% | −7.40% | −16.61% |
Return on Invested Capital (Normalized) | −57.48% | −9.25% | −15.27% |
Return on Assets
TANVF
6617
09966
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Wtxvmwyc | Zzcf | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Qshphyrr | Fvylw | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ffppxlqj | Hyjlqm | $97.8 Bil | |
MRNA
| Moderna Inc | Ljrqnrqsc | Fckb | $41.3 Bil | |
ARGX
| argenx SE ADR | Hxvzryhwx | Tdwd | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Klxmcsqx | Gnf | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Mqkjxypf | Lncvxb | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Vsdvrvmq | Xjbcmgx | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Klrmhvhkm | Dhgzl | $12.5 Bil | |
INCY
| Incyte Corp | Nqpvfkx | Zlsyzz | $11.6 Bil |